the Efficiency of a drug favipiravir in the treatment of patients hospitalized with the novel coronavirus infection, check in 17 medical institutions of Russia, said the Ministry of health. Permission for clinical studies issued by the Russian pharmaceutical manufacturer.

the Drug is designed against different types of RNA viruses has previously proven effective in the treatment of severe infections caused by high viral load and have been approved as anti-influenza drugs in Japan. According to Chinese scientists, favipiravir has established itself as the cure COVID-19.